Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novartis Oncology announces Glivec name change in U.S.

May 3, 2001

Nonestrogenic steroid sulfatase inhibitors identified at Jenapharm

May 2, 2001

Water-soluble prodrug prepared to overcome clinical limitations of quercetin

May 2, 2001

CASB6411 polypeptides and polynucleotides and use in cancer treatment, diagnosis

May 2, 2001

Inex and Elan form joint venture to develop and commercialize Onco TCS

May 2, 2001

Small-molecule dual alphavbeta3/alphavbeta5 integrin inhibitor Sch-221153 inhibits angiogenesis

May 2, 2001

Novogen creates new company to develop phenoxodiol

May 2, 2001

LEraf-AON, a liposomal antisense oligodeoxyribonucleotide for enhancing radiation effects

May 2, 2001

Myriad Genetics' MPC-7869 stabilizes PSA levels in phase II

May 2, 2001

Lilly claims new use of parathyroid hormone

April 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026